Actos® (Pioglitazone)

Kane Legal is reviewing the following birth defect injuries related to Actos®:

• Bladder Cancer
• Diabetic Macular Edema

If you or a loved one has taken Actos® and have been diagnosed with bladder cancer, please call KANE LEGAL for a free consultation.

Actos is a diabetic drug prescribed for adults with Type 2 diabetes to maintain normal blood sugar levels. Since it came out to the market in 1999 by Takeda Pharmaceuticals, there were many concerns about the possibility of heart failure and lactic acidosis linked with its use.

Recently, Actos has been under investigations from various groups as a possible cause of bladder cancer and as a result, both Germany and France governments have already pulled the medication off the shelves and stopped all sales of the drug in their respective countries.

The study responsible for banning Actos in European countries was an official report from a scientific study group in Europe with approximately 150,000 patients that that one fifth of those who developed bladder cancer also took Actos.

In June of 2011, partly in response to the European studies, the FDA issued a new report for physicians indicating a possible link between Actos and bladder cancer. Doctors are advised not to prescribe this medication for those already afflicted with this disease. However, to this day the FDA has not included this warning on the label of Actos.

If you or a loved one has been diagnosed with bladder cancer from taking Actos, please contact our pharmacist attorney at KANE LEGAL today for a free consultation.